Feasibility, safety, and functional outcomes using the neurological controlled Hybrid Assistive Limb exoskeleton (HAL®) following acute incomplete and complete spinal cord injury - Results of 50 patients.
Mirko AachThomas Armin SchildhauerAmrei ZieriacksOliver JansenMartin WeßlingAlexis BrinkemperDennis GrasmückePublished in: The journal of spinal cord medicine (2023)
German Clinical Trials Register identifier: DRKS00010250..
Keyphrases
- spinal cord injury
- clinical trial
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- liver failure
- prognostic factors
- peritoneal dialysis
- randomized controlled trial
- intensive care unit
- drug induced
- respiratory failure
- extracorporeal membrane oxygenation
- study protocol
- hepatitis b virus
- blood brain barrier
- open label